{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:14:43Z","timestamp":1792401283494,"version":"4.4.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.4065\/mcp.2010.0099","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T17:23:45Z","timestamp":1283361825000},"page":"838-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":590,"title":["Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment"],"prefix":"10.4065","volume":"85","author":[{"given":"Lorraine C.","family":"Pelosof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.4065\/mcp.2010.0099_bib1","first-page":"335","article-title":"\u00dcber Hirnsymptome bei Carcinomatose ohne nachweisbare Ver\u00e4nderungen im Gehirn","author":"Oppenheim","year":"1888","journal-title":"Charit\u00e9-Annalen (Berlin)"},{"key":"10.4065\/mcp.2010.0099_bib2","first-page":"197","article-title":"La Polyradiculon\u00e9urite canc\u00e9reuse m\u00e9tastatique","volume":"30","author":"Guichard","year":"1949","journal-title":"J Med Lyon"},{"key":"10.4065\/mcp.2010.0099_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00405-005-0942-1","article-title":"Paraneoplastic syndromes in patients with primary malignancies of the head and neck: four cases and a review of the literature","volume":"263","author":"Baijens","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.4065\/mcp.2010.0099_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2005.04.004","article-title":"Metabolic emergencies","volume":"58","author":"Spinazze","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.4065\/mcp.2010.0099_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00520-007-0309-9","article-title":"Diagnosis and management of hyponatremia in cancer patients","volume":"15","author":"Raftopoulos","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.4065\/mcp.2010.0099_bib6","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(02)94708-3","article-title":"Vasopressin: a new target for the treatment of heart failure","volume":"146","author":"Lee","year":"2003","journal-title":"Am Heart J"},{"key":"10.4065\/mcp.2010.0099_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/092986708783497346","article-title":"Medical treatment of malignancy-associated hypercalcemia","volume":"15","author":"Lumachi","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.4065\/mcp.2010.0099_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/thy.2005.15.618","article-title":"Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature","volume":"15","author":"Barbosa","year":"2005","journal-title":"Thyroid"},{"key":"10.4065\/mcp.2010.0099_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.semtcvs.2006.08.005","article-title":"Bronchial typical carcinoid tumors","volume":"18","author":"Morandi","year":"2006","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.4065\/mcp.2010.0099_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.ten.0000188475.05398.09","article-title":"Clinical approach of Cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor","volume":"15","author":"Teves","year":"2005","journal-title":"Endocrinologist"},{"key":"10.4065\/mcp.2010.0099_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1464-410X.2007.07294.x","article-title":"Paraneoplastic Cushing's syndrome in prostate cancer: a difficult management problem","volume":"101","author":"Nimalasena","year":"2008","journal-title":"BJU Int"},{"key":"10.4065\/mcp.2010.0099_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022308429992","article-title":"Medical therapy of Cushing's disease","volume":"5","author":"Nieman","year":"2002","journal-title":"Pituitary"},{"issue":"4","key":"10.4065\/mcp.2010.0099_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.ten.0000226008.02412.0b","article-title":"Diagnosis and management of nonislet cell tumor hypoglycemia: case series and review of the literature","volume":"16","author":"Nayar","year":"2006","journal-title":"Endocrinologist"},{"key":"10.4065\/mcp.2010.0099_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2265.1998.00564.x","article-title":"Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH)","volume":"49","author":"Teale","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4065\/mcp.2010.0099_bib17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1585::AID-CNCR22>3.0.CO;2-#","article-title":"The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia","volume":"82","author":"Hoff","year":"1998","journal-title":"Cancer"},{"key":"10.4065\/mcp.2010.0099_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.emc.2009.01.007","article-title":"Electrolyte complications of malignancy","volume":"27","author":"Kacprowicz","year":"2009","journal-title":"Emerg Med Clin North Am"},{"key":"10.4065\/mcp.2010.0099_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/jcem.84.5.5677-1","article-title":"Treatment of hemangiopericytoma-induced hypoglycemia with growth hormone and corticosteroids","volume":"84","author":"Gullo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/mcp.2010.0099_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2265.2007.03136.x","article-title":"Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism","volume":"68","author":"Vezzosi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4065\/mcp.2010.0099_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/PL00005139","article-title":"Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist","volume":"357","author":"Tahara","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.4065\/mcp.2010.0099_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/mcp.2010.0099_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients","volume":"112","author":"Ralston","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0099_bib24","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1073\/pnas.87.11.4149","article-title":"Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy","volume":"87","author":"Bockman","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/mcp.2010.0099_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4065\/mcp.2010.0099_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/en.2006-0738","article-title":"Diazoxide prevents diabetes through inhibiting pancreatic \u03b2-cells from apoptosis via Bcl-2\/Bax rate and p38-\u03b2 mitogen-activated protein kinase","volume":"148","author":"Huang","year":"2007","journal-title":"Endocrinology"},{"key":"10.4065\/mcp.2010.0099_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1634\/theoncologist.11-3-292","article-title":"Managing paraneoplastic neurological disorders","volume":"11","author":"de Beukelaar","year":"2006","journal-title":"Oncologist"},{"key":"10.4065\/mcp.2010.0099_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","article-title":"Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration","volume":"47","author":"Albert","year":"2000","journal-title":"Ann Neurol"},{"key":"10.4065\/mcp.2010.0099_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.4065\/mcp.2010.0099_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.4065\/mcp.2010.0099_bib31","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.4065\/mcp.2010.0099_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp.2006.104513","article-title":"Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus","volume":"78","author":"Shimazaki","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/mcp.2010.0099_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1215\/S1152851703000395","article-title":"Immunomodulatory treatment trial for paraneoplastic neurological disorders","volume":"6","author":"Vernino","year":"2004","journal-title":"Neuro-Oncol"},{"key":"10.4065\/mcp.2010.0099_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1215\/15228517-2006-013","article-title":"Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study","volume":"9","author":"Rojas-Marcos","year":"2007","journal-title":"Neuro-Oncol"},{"key":"10.4065\/mcp.2010.0099_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes","volume":"253","author":"Shams'ili","year":"2006","journal-title":"J Neurol"},{"key":"10.4065\/mcp.2010.0099_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/mcp.2010.0099_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.56.2.172","article-title":"Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors","volume":"56","author":"Antoine","year":"1999","journal-title":"Arch Neurol"},{"key":"10.4065\/mcp.2010.0099_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/mcp.2010.0099_bib39","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1523\/JNEUROSCI.21-18-07203.2001","article-title":"Isolation and expression pattern of human Unc-33-like phosphoprotein 6\/collapsin response mediator protein 5 (Ulip6\/CRMP5): coexistence with Ulip2\/CRMP2 in Sema3a-sensitive oligodendrocytes","volume":"21","author":"Ricard","year":"2001","journal-title":"J Neurosci"},{"key":"10.4065\/mcp.2010.0099_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"key":"10.4065\/mcp.2010.0099_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(91)90184-Z","article-title":"HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal","volume":"67","author":"Szabo","year":"1991","journal-title":"Cell"},{"key":"10.4065\/mcp.2010.0099_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"Molecular and clinical diversity in paraneoplastic immunity to Ma proteins","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"key":"10.4065\/mcp.2010.0099_bib43","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer","volume":"340","author":"Voltz","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.4065\/mcp.2010.0099_bib44","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/CCO.0b013e3283306647","article-title":"Update on paraneoplastic neurological syndromes","volume":"21","author":"Didelot","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.4065\/mcp.2010.0099_bib45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.4065\/mcp.2010.0099_bib46","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2153::AID-CNCR16>3.0.CO;2-Y","article-title":"Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin: a case report","volume":"78","author":"David","year":"1996","journal-title":"Cancer"},{"key":"10.4065\/mcp.2010.0099_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","article-title":"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system","volume":"11","author":"Buckanovich","year":"1993","journal-title":"Neuron"},{"key":"10.4065\/mcp.2010.0099_bib48","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1073\/pnas.95.22.13254","article-title":"The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia","volume":"95","author":"Yang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/mcp.2010.0099_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0099_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010050853","article-title":"Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system","volume":"96","author":"Graus","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.4065\/mcp.2010.0099_bib51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0099_bib52","first-page":"2136","article-title":"Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors","volume":"60","author":"Darnell","year":"2000","journal-title":"Cancer Res"},{"key":"10.4065\/mcp.2010.0099_bib53","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.88.8.3451","article-title":"Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration","volume":"88","author":"Fathallah-Shaykh","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/mcp.2010.0099_bib54","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.86.8.2873","article-title":"Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration","volume":"86","author":"Furneaux","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/mcp.2010.0099_bib55","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1101\/gad.13.16.2087","article-title":"The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival","volume":"13","author":"Okano","year":"1999","journal-title":"Genes Dev"},{"key":"10.4065\/mcp.2010.0099_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(01)00368-X","article-title":"Suppression of the transcriptional activity and DNA binding of nuclear factor-kappa B by a paraneoplastic cerebellar degeneration-associated antigen","volume":"119","author":"Sakai","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.4065\/mcp.2010.0099_bib57","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM198912073212303","article-title":"3,4-diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome","volume":"321","author":"McEvoy","year":"1989","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.54.3.603","article-title":"A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome","volume":"54","author":"Sanders","year":"2000","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0099_bib59","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1146::AID-MUS9>3.0.CO;2-8","article-title":"Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome","volume":"20","author":"Oh","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.2009.35","article-title":"Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"86","author":"Wirtz","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/mcp.2010.0099_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.34.4.480","article-title":"Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome","volume":"34","author":"Newsom-Davis","year":"1984","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0099_bib62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","article-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"47","author":"Bain","year":"1996","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.4065\/mcp.2010.0099_bib63","doi-asserted-by":"crossref","first-page":"I14","DOI":"10.1007\/s00415-005-1104-5","article-title":"IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status","volume":"252","author":"Illa","year":"2005","journal-title":"J Neurol"},{"key":"10.4065\/mcp.2010.0099_bib64","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.4065\/mcp.2010.0099_bib65","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.clinph.2004.12.013","article-title":"MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence","volume":"116","author":"Oh","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.4065\/mcp.2010.0099_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.4065\/mcp.2010.0099_bib67","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"10.4065\/mcp.2010.0099_bib68","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.4065\/mcp.2010.0099_bib69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mus.21462","article-title":"Factors associated with response to calcineurin inhibitors in myasthenia gravis","volume":"41","author":"Nagane","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib70","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.WNL.0000094122.88929.0B","article-title":"Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability","volume":"61","author":"Meriggioli","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.4065\/mcp.2010.0099_bib71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/mus.21521","article-title":"Rituximab in the management of refractory myasthenia gravis","volume":"41","author":"Zebardast","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1196\/annals.1405.033","article-title":"Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis","volume":"1132","author":"Drachman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.4065\/mcp.2010.0099_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10286-008-0488-6","article-title":"Antibody testing as a diagnostic tool in autonomic disorders","volume":"19","author":"Vernino","year":"2009","journal-title":"Clin Auton Res"},{"key":"10.4065\/mcp.2010.0099_bib74","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1572-0241.2003.07313.x","article-title":"Repeated neostigmine dosage as palliative treatment for chronic colonic pseudo-obstruction in a patient with autonomic paraneoplastic neuropathy","volume":"98","author":"Calvet","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/mcp.2010.0099_bib75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00019052-200210000-00011","article-title":"Autonomic neuropathies","volume":"15","author":"Low","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.4065\/mcp.2010.0099_bib76","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjmed.2007.02.023","article-title":"Orthostatic hypotension in the elderly: diagnosis and treatment","volume":"120","author":"Gupta","year":"2007","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0099_bib77","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1152\/jn.00408.2003","article-title":"Experimental autoimmune autonomic neuropathy","volume":"90","author":"Vernino","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.4065\/mcp.2010.0099_bib78","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1576::AID-MUS13>3.0.CO;2-Z","article-title":"Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature","volume":"20","author":"Oh","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib79","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awp136","article-title":"The pattern and diagnostic criteria of sensory neuronopathy: a case-control study","volume":"132","author":"Camdessanche","year":"2009","journal-title":"Brain"},{"key":"10.4065\/mcp.2010.0099_bib80","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.4065\/mcp.2010.0099_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","article-title":"Positron Emission Tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review","volume":"67","author":"McKeon","year":"2010","journal-title":"Arch Neurol"},{"key":"10.4065\/mcp.2010.0099_bib82","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.4065\/mcp.2010.0099_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mus.880090608","article-title":"Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG","volume":"9","author":"Kim","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.4065\/mcp.2010.0099_bib85","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2008.03.002","article-title":"Regulatory T cells in paraneoplastic neurological syndromes","volume":"196","author":"Tani","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.4065\/mcp.2010.0099_bib86","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","article-title":"Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function","volume":"179","author":"Kessel","year":"2007","journal-title":"J Immunol"},{"key":"10.4065\/mcp.2010.0099_bib87","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.4065\/mcp.2010.0099_bib88","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood"},{"key":"10.4065\/mcp.2010.0099_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2141.1985.tb07417.x","article-title":"Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura","volume":"60","author":"Delfraissy","year":"1985","journal-title":"Br J Haematol"},{"key":"10.4065\/mcp.2010.0099_bib90","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1102::AID-MUS2>3.0.CO;2-C","article-title":"Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases","volume":"20","author":"Koffman","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.4065\/mcp.2010.0099_bib91","first-page":"697","article-title":"Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura","volume":"53","author":"Tsubakio","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.4065\/mcp.2010.0099_bib92","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V98.10.3136","article-title":"Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect","volume":"98","author":"Bleeker","year":"2001","journal-title":"Blood"},{"key":"10.4065\/mcp.2010.0099_bib93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases","volume":"340","author":"Yu","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib94","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/qjmed\/93.11.751","article-title":"Nephrotoxicity of intravenous immunoglobulin","volume":"93","author":"Levy","year":"2000","journal-title":"QJM"},{"key":"10.4065\/mcp.2010.0099_bib95","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archinte.154.17.1985","article-title":"Intravenous immunoglobulin-induced osmotic nephrosis","volume":"154","author":"Ahsan","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.4065\/mcp.2010.0099_bib96","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib97","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","article-title":"Drug removal by plasmapheresis: an evidence-based review","volume":"27","author":"Ibrahim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.4065\/mcp.2010.0099_bib98","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00415-008-0845-3","article-title":"Relative frequency of VGKC and \u2018classical\u2019 paraneoplastic antibodies in patients with limbic encephalitis","volume":"255","author":"Jarius","year":"2008","journal-title":"J Neurol"},{"key":"10.4065\/mcp.2010.0099_bib99","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival","volume":"15","author":"Graus","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.4065\/mcp.2010.0099_bib100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3322\/caac.20005","article-title":"Cutaneous manifestations of internal malignancy","volume":"59","author":"Thiers","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.4065\/mcp.2010.0099_bib101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome\u2013a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.4065\/mcp.2010.0099_bib102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/gyno.2001.6472","article-title":"Acanthosis nigricans with endometrial carcinoma: case report and review of the literature","volume":"84","author":"Mekhail","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.4065\/mcp.2010.0099_bib103","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1365-2133.1999.03116.x","article-title":"Malignant acanthosis nigricans: potential role of chemotherapy","volume":"141","author":"Anderson","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib104","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.4065\/mcp.2010.0099_bib105","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.4065\/mcp.2010.0099_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/10428190601137336","article-title":"Skin lesions in chronic lymphocytic leukemia","volume":"48","author":"Robak","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/mcp.2010.0099_bib108","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SMJ.0b013e318191b8c0","article-title":"Erythroderma as the first manifestation of colon cancer","volume":"102","author":"Chong","year":"2009","journal-title":"South Med J"},{"key":"10.4065\/mcp.2010.0099_bib109","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2007.08.004","article-title":"Mycosis fungoides","volume":"65","author":"Zinzani","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.4065\/mcp.2010.0099_bib110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-4632.2008.03526.x","article-title":"Specific cutaneous manifestations in adult T-cell leukemia\/lymphoma","volume":"47","author":"Pezeshkpoor","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-4632.2009.03834.x","article-title":"Erythroderma associated with leukocytosis in premalignant myeloproliferative disorder","volume":"48","author":"Takatsuka","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/JTO.0b013e3181952915","article-title":"Hypertrophic osteoarthropathy masquerading as lower extremity cellulitis and response to bisphosphonates","volume":"4","author":"Mauricio","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.4065\/mcp.2010.0099_bib113","first-page":"253","article-title":"A case of finger clubbing associated with nasopharyngeal carcinoma in a young girl, and review of pathophysiology","volume":"59","author":"Ali","year":"2009","journal-title":"J Pak Med Assoc"},{"key":"10.4065\/mcp.2010.0099_bib114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/RLU.0b013e3181966dfb","article-title":"Rhabdomyosarcoma associated hypertrophic osteoarthropathy in a child: detection by bone scintigraphy","volume":"34","author":"Garganese","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.4065\/mcp.2010.0099_bib115","first-page":"181","article-title":"Cutaneous vasculitis as a paraneoplastic syndrome in childhood","volume":"32","author":"Pelajo","year":"2007","journal-title":"Acta Reumatol Port"},{"key":"10.4065\/mcp.2010.0099_bib116","first-page":"294","article-title":"Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases","volume":"35","author":"Solans-Laque","year":"2008","journal-title":"J Rheumatol"},{"key":"10.4065\/mcp.2010.0099_bib117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0019-509X.49159","article-title":"Multiple myeloma with paraneoplastic leucocytoclastic vasculitis","volume":"46","author":"Jain","year":"2009","journal-title":"Indian J Cancer"},{"key":"10.4065\/mcp.2010.0099_bib119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/0378-6323.53130","article-title":"Cutaneous vasculitides: clinico-pathological correlation","volume":"75","author":"Gupta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.4065\/mcp.2010.0099_bib120","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib121","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000070972","article-title":"Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A","volume":"109","author":"Gergely","year":"2003","journal-title":"Acta Haematol"},{"key":"10.4065\/mcp.2010.0099_bib122","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib123","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.4065\/mcp.2010.0099_bib124","first-page":"105","article-title":"Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone [letter]","volume":"63","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"key":"10.4065\/mcp.2010.0099_bib125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.rhu.0000231359.41352.c0","article-title":"Polymyalgia rheumatica and breast cancer","volume":"12","author":"Keith","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.4065\/mcp.2010.0099_bib127","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000260650.43402.b6","article-title":"More on polymyalgia rheumatica (PMR) as a paraneoplastic rheumatic syndrome in the elderly (bicytopenia and PMR preceding acute myeloid leukemia)","volume":"13","author":"Anton","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.4065\/mcp.2010.0099_bib128","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","article-title":"Treatment of polymyalgia rheumatica: a systematic review","volume":"169","author":"Hernandez-Rodriguez","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.4065\/mcp.2010.0099_bib129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1590\/S0365-05962006000500011","article-title":"Sweet's syndrome associated with neoplasms","volume":"81","author":"Franco","year":"2006","journal-title":"An Bras Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000250516","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with potassium iodide","volume":"160","author":"Horio","year":"1980","journal-title":"Dermatologica"},{"issue":"4","key":"10.4065\/mcp.2010.0099_bib131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1981.tb00785.x","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with colchicine [letter]","volume":"105","author":"Suehisa","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib132","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2133.1999.02747.x","article-title":"Colchicine for Sweet's syndrome: a study of 20 cases","volume":"140","author":"Maillard","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib133","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4065\/mcp.2010.0099_bib134","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.4065\/mcp.2010.0099_bib135","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/path.1565","article-title":"Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing","volume":"203","author":"Atkinson","year":"2004","journal-title":"J Pathol"},{"issue":"8","key":"10.4065\/mcp.2010.0099_bib136","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ncprheum0252","article-title":"Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclooxygenase-2-derived prostaglandin E2","volume":"2","author":"Kozak","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.4065\/mcp.2010.0099_bib137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jso.20173","article-title":"Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF","volume":"89","author":"Anagnostopoulos","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.4065\/mcp.2010.0099_bib138","series-title":"Harrison's Principles of Internal Medicine","first-page":"617","article-title":"Paraneoplastic syndromes: endocrinologic\/hematologic","author":"Jameson","year":"2008"},{"key":"10.4065\/mcp.2010.0099_bib139","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/COC.0b013e3181b01b17","article-title":"The link between cancer and venous thromboembolism: a review","volume":"32","author":"Kessler","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.4065\/mcp.2010.0099_bib140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-822974","article-title":"Platelets and angiogenesis in malignancy","volume":"30","author":"Sierko","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.4065\/mcp.2010.0099_bib141","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic","volume":"133","author":"Tefferi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.4065\/mcp.2010.0099_bib142","series-title":"Harrison's Principles of Internal Medicine","first-page":"375","article-title":"Disorders of granulocytes and monocytes","author":"Holland","year":"2008"},{"key":"10.4065\/mcp.2010.0099_bib143","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-89-2-167","article-title":"Therapy of the hypereosinophilic syndrome","volume":"89","author":"Parrillo","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0099_bib144","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders","volume":"23","author":"Valent","year":"2009","journal-title":"Blood Rev"},{"key":"10.4065\/mcp.2010.0099_bib145","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1378\/chest.71.6.789","article-title":"Progressive hypereosinophilia with lung nodules due to thyroid carcinoma","volume":"71","author":"Miller","year":"1977","journal-title":"Chest"},{"key":"10.4065\/mcp.2010.0099_bib146","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1572-0241.2007.01772_16.x","article-title":"Pancreatic cancer manifesting as liver metastases and eosinophillic leukemoid reaction: a case report and review of literature","volume":"103","author":"Ashdhir","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/mcp.2010.0099_bib147","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3904\/kjim.2005.20.3.247","article-title":"A case of uterine cervical cancer presenting with granulocytosis","volume":"20","author":"Ahn","year":"2005","journal-title":"Korean J Intern Med"},{"key":"10.4065\/mcp.2010.0099_bib148","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1478-3231.2007.01468.x","article-title":"Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review","volume":"27","author":"Araki","year":"2007","journal-title":"Liver Int"},{"key":"10.4065\/mcp.2010.0099_bib149","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.JTO.0000263705.23579.ee","article-title":"Pure red cell aplasia and thymoma","volume":"2","author":"Thompson","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.4065\/mcp.2010.0099_bib150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.hoc.2009.01.009","article-title":"Diagnosis and management of acquired pure red cell aplasia","volume":"23","author":"Sawada","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/mcp.2010.0099_bib151","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood.V63.2.277.277","article-title":"Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients","volume":"63","author":"Clark","year":"1984","journal-title":"Blood"},{"issue":"5","key":"10.4065\/mcp.2010.0099_bib152","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12185-009-0423-1","article-title":"Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?","volume":"90","author":"Tanna","year":"2009","journal-title":"Int J Hematol"},{"key":"10.4065\/mcp.2010.0099_bib153","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.0902-4441.2003.00196.x","article-title":"Monoclonal antibodies in the treatment of autoimmune cytopenias","volume":"72","author":"Robak","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.4065\/mcp.2010.0099_bib154","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1600-0609.2003.00055.x","article-title":"Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H","volume":"70","author":"Rodon","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.4065\/mcp.2010.0099_bib155","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V82.7.2261.2261","article-title":"Role of interleukin-6 in paraneoplastic thrombocytosis","volume":"82","author":"Blay","year":"1993","journal-title":"Blood"},{"key":"10.4065\/mcp.2010.0099_bib156","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00432-009-0625-1","article-title":"Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer","volume":"135","author":"Chen","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.4065\/mcp.2010.0099_bib157","first-page":"14","article-title":"Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte\/macrophage colony-stimulating factor (GM-CSF), and interleukin-5","volume":"3","author":"Sonoda","year":"1989","journal-title":"Leukemia"},{"issue":"2","key":"10.4065\/mcp.2010.0099_bib158","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4065\/mcp.2009.0503","article-title":"Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update","volume":"85","author":"Tefferi","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/mcp.2010.0099_bib159","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00402777","article-title":"Leukocytosis in non hematological malignancies\u2013a possible tumor-associated marker","volume":"111","author":"Shoenfeld","year":"1986","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.4065\/mcp.2010.0099_bib160","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/cncr.24480","article-title":"Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study","volume":"115","author":"Granger","year":"2009","journal-title":"Cancer"},{"key":"10.4065\/mcp.2010.0099_bib161","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1097-0142(19870815)60:4<903::AID-CNCR2820600431>3.0.CO;2-6","article-title":"Leukocytosis and large cell lung cancer: a frequent association","volume":"60","author":"Ascensao","year":"1987","journal-title":"Cancer"},{"key":"10.4065\/mcp.2010.0099_bib162","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831","article-title":"The pathophysiology of pure red cell aplasia: implications for therapy","volume":"87","author":"Charles","year":"1996","journal-title":"Blood"},{"key":"10.4065\/mcp.2010.0099_bib163","first-page":"220","article-title":"Epoetin-induced pure red cell aplasia successfully treated with androgens","volume":"19","author":"Sanchez de la Nieta","year":"2006","journal-title":"J Nephrol"},{"key":"10.4065\/mcp.2010.0099_bib164","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.ASN.0000107561.59698.42","article-title":"Anti-erythropoietin antibodies and pure red cell aplasia","volume":"15","author":"Rossert","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.4065\/mcp.2010.0099_bib165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(94)90306-9","article-title":"Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis","volume":"97","author":"Tefferi","year":"1994","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0099_bib166","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(94)90150-3","article-title":"Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases","volume":"96","author":"Buss","year":"1994","journal-title":"Am J Med"},{"key":"10.4065\/mcp.2010.0099_bib167","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajh.21183","article-title":"Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy","volume":"83","author":"Tefferi","year":"2008","journal-title":"Am J Hematol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611602140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611602140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:10:55Z","timestamp":1740481855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611602140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":167,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0025619611602140"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2010.0099","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2010.0099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}